Related Experiment Video
Updated: Jul 10, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.1K
Federated Learning for multi-omics: a performance evaluation in Parkinson's disease
Benjamin Danek1,2,3, Mary B Makarious4,5,6, Anant Dadu2,3
1Department of Computer Science, University of Illinois at Urbana-Champaign, Champaign, IL, 61820, USA.
Biorxiv : the Preprint Server for Biology
|November 21, 2023
Summary
Federated learning (FL) shows promise for training machine learning (ML) models on multi-omics Parkinson's Disease data, achieving performance close to centrally trained models. Data dispersion impacts FL model effectiveness.
Area of Science:
- Computational biology
- Genomics
- Machine learning
Background:
- Machine learning (ML) application in omics is limited by data access.
- Federated learning (FL) offers a solution for collaborative, privacy-preserving data curation.
Approach:
- Compared FL models with centrally trained ML models for multi-omics Parkinson's Disease prediction.
- Evaluated performance using AUC-PR, analyzing the impact of sample dispersion.
Key Points:
- FL model performance closely mirrors centrally trained ML models.
- The most effective FL model achieved an AUC-PR of 0.876 ± 0.009.
- Sample dispersion within a federation significantly influences model performance.
Conclusions:
- FL is a viable approach for multi-omics studies, overcoming data access limitations.
- Open-source FL frameworks can be effectively implemented for collaborative research.
- Further research is needed to optimize FL strategies for omics data challenges.
More Related Videos
Related Concept Videos
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560
Parkinson's Disease: Treatment
278
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
278

